Glimpsing Into the Future: Advances in Prenatal Screening for Aneuploidy – Mainpro+

After completion of the program, participants will be able to:

1. Offer options for prenatal screening for trisomy 21, 18, and 13 to all women.
2. Differentiate among available prenatal genetic screening modalities for trisomy 21, 18, and 13.
3. Counsel patients about the benefits, limitations, test-result interpretation, and outcomes of prenatal screening for trisomy 21, 18, and 13 in the primary care setting.